Literature DB >> 23741984

Heterogeneous nuclear ribonucleoproteins and their interactors are a major class of deregulated proteins in anaplastic astrocytoma: a grade III malignant glioma.

Ravindra Varma Polisetty1, Poonam Gautam, Manoj Kumar Gupta, Rakesh Sharma, Megha S Uppin, Sundaram Challa, Praveen Ankathi, Aniruddh K Purohit, Durairaj Renu, H C Harsha, Akhilesh Pandey, Ravi Sirdeshmukh.   

Abstract

Anaplastic astrocytoma is a high grade malignant glioma (WHO grade III) of the central nervous system which arises from a low grade II tumor and invariably progresses into lethal glioblastoma (WHO grade IV). We have studied differentially expressed proteins from the microsomal fraction of the clinical specimens of these tumors, using iTRAQ and high-resolution mass spectrometry followed by immunohistochemistry for representative proteins on tissue sections. A total of 2642 proteins were identified, 266 of them with minimum 2 peptide signatures and 2-fold change in expression. The major groups of proteins revealed to be differentially expressed were associated with key cellular processes such as post transcriptional processing, protein translation, and acute phase response signaling. A distinct inclusion among these important proteins is 10 heterogeneous nuclear ribonucleoproteins (hnRNPs) and their interacting partners which have regulatory functions in the cell. hnRNP-mediated post transcriptional events are known to play a major role in mRNA processing, stability, and distribution. Their altered levels have also been observed by us in lower (diffused astrocytoma) and higher (glioblastoma) grades of gliomas, and membrane localization of hnRNPs has also been documented in the literature. hnRNPs may thus be major factors underlying global gene expression changes observed in glial tumors while their differential presence in the microsomal fraction suggests yet additional and unknown roles in tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23741984     DOI: 10.1021/pr400339h

Source DB:  PubMed          Journal:  J Proteome Res        ISSN: 1535-3893            Impact factor:   4.466


  5 in total

1.  Network analysis of microRNAs, transcription factors, target genes and host genes in human anaplastic astrocytoma.

Authors:  Luchen Xue; Zhiwen Xu; Kunhao Wang; Ning Wang; Xiaoxu Zhang; Shang Wang
Journal:  Exp Ther Med       Date:  2016-04-20       Impact factor: 2.447

2.  Microsomal membrane proteome of low grade diffuse astrocytomas: Differentially expressed proteins and candidate surveillance biomarkers.

Authors:  Ravindra Varma Polisetty; Poonam Gautam; Manoj Kumar Gupta; Rakesh Sharma; Harsha Gowda; Durairaj Renu; Bhadravathi Marigowda Shivakumar; Akhila Lakshmikantha; Kiran Mariswamappa; Praveen Ankathi; Aniruddh K Purohit; Megha S Uppin; Challa Sundaram; Ravi Sirdeshmukh
Journal:  Sci Rep       Date:  2016-06-01       Impact factor: 4.379

3.  Differential proteomics analysis of low- and high-grade of astrocytoma using iTRAQ quantification.

Authors:  Tong Ren; Shide Lin; Zhongfeng Wang; Aijia Shang
Journal:  Onco Targets Ther       Date:  2016-09-27       Impact factor: 4.147

4.  Altered transcriptional regulatory proteins in glioblastoma and YBX1 as a potential regulator of tumor invasion.

Authors:  Manoj Kumar Gupta; Ravindra Varma Polisetty; Rakesh Sharma; Raksha A Ganesh; Harsha Gowda; Aniruddh K Purohit; Praveen Ankathi; Komal Prasad; Kiran Mariswamappa; Akhila Lakshmikantha; Megha S Uppin; Challa Sundaram; Poonam Gautam; Ravi Sirdeshmukh
Journal:  Sci Rep       Date:  2019-07-29       Impact factor: 4.379

5.  Quantitative proteomic analysis of GnRH agonist treated GBM cell line LN229 revealed regulatory proteins inhibiting cancer cell proliferation.

Authors:  Priyanka H Tripathi; Javed Akhtar; Jyoti Arora; Ravindra Kumar Saran; Neetu Mishra; Ravindra Varma Polisetty; Ravi Sirdeshmukh; Poonam Gautam
Journal:  BMC Cancer       Date:  2022-02-02       Impact factor: 4.430

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.